x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   Under PM Modi’s leadership India rising as major economic power, reclaiming its past glory: LG Sinha | One month after Kishtwar tragedy, mother’s unending wait for her missing kins continues | Safety audit of more than 50% schools pending, resumption of offline classes uncertain | Land subsidence crumbles hopes, dreams | PM Modi visits Aizawl, Mizoram; lays foundation stones of works worth over Rs 9,000 crore | Empower elected J&K Govt in accordance with aspirations of people: CM Omar | Doda: Markets return to life as restrictions eased for 6 hours | Schools to reopen tomorrow: DC | NCB Sgr busts major narcotics smuggling network; 3 arrested | Woman injured in bear attack | Drone seized near LoC | Want to make Manipur symbol of peace, prosperity: PM Modi | UPITS 2025: A grand confluence of development, investment at India Expo Mart | Cultural Unit Srinagar of DIPR organizes cultural programme | Div Com stresses on collaborative efforts for Aerospace Safety | Justice Vinod Chatterji Koul inaugurates 3rd National Lok Adalat at Baramulla | Preparations for Sewa Parv-2025 reviewed at Kupwara | CM instructs for enhanced facilities for attendants, strengthening of sanitation in hospital | Jammu Rural Police Khour arrests third absconder in FIR 107/2023 case | Miran Sahib police arrests one accused in attempt to murder case | PHC Chatroo, HW Centre Udil Gojran receive Prestigious NQAS Certification | DC Udhampur reviews preparations for Sewa Parv-2025 | DLIC approves 334 Youth Entrepreneurship cases under Mission Yuya in Kulgam | ADC Bhaderwah convenes meeting with members of civil society | DC Kulgam visits District Hospital; directs expeditious completion of ongoing projects | National Lok Adalat held at ADR Centre Court Complex Kathua | Rich Harvest hosts CBSE capacity building programme | White water rafting expedition flagged off by Tiger Division | DAV Players’ outshine in Maharaja Ranjit Singh Cup | Inspiring Celebration of Hindi Diwas held | Apni Party Delegation Submits Memorandum to Joint Commissioner | Missing person traced, reunited with family | Quiz Competition on Population Geography held at GCW Udhampur | Cadet Swastik Sharma Brings National Glory to PWS Pathankot | Can a combined MBBS-Ayurveda degree produce competent doctors? | Before Physics, There Was Math: A Journey Through Human History” | Footpaths: The Lost Spaces of Urban India | C.P Radhakrishnan: - From RSS Worker to Constitutional Custodian | Back Issues  
 
news details
Forest fire triggers mine blasts along LoC in Poonch
10/24/2020 12:44:00 AM

EARLY TIMES REPORT

POONCH, Oct, 23: Aforest fire triggered several mine blasts along the Line of Control in Jammu and Kashmir’s Poonch district on Friday, officials said. The fire broke out in Balakot sector and spread to few adjoining areas, they said. Some anti-personnel mines exploded due to the fire, triggering panic among the residents, the officials said. The blaze was brought under control by Army and forest department personnel within a few hours, they said. The Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centres across India and a total of 26,000 people will be participating in the Phase 3 trials.
The Drug Controller General of India (DGCI) has already granted Bharat Biotech a go ahead for the Phase 3 trials after successful completion of Phase 1 and 2 clinical trials. However, the permission for the Phase 3 trials of COVAXIN is subject to minor changes in the primary efficacy endpoint for the symptomatic cases. The primary efficacy endpoint is the outcome by which the effectiveness of treatments in a clinical trial is evaluated. A carefully chosen endpoint can ensure no bias. A primary efficacy endpoint needs to be specified before the start of the clinical trial. “The firm has presented their data from Phase I and II along with animal challenge data in two species including NHP on the Inactivated Corona Virus Vaccine (BBV152) along with the proposal to conduct event-driven Phase III clinical trial to assess the efficacy of the vaccine,” the expert panel of Subject Expert Committee (SEC) said. Developed by Bharat Biotech along with the Indian Council of Medical Research and National Institute of Virology, Covaxin was India’s first indigenous vaccine candidate against the Covid-19.
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
 
Early Times Android App
STOCK UPDATE
  
BSE Sensex
NSE Nifty
 
CRICKET UPDATE
 
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU